Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Cetuximab can cause eyelash growth, which is rare but manageable.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Suppressing certain hormones might help prevent prostate cancer.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Dermoscopy is an effective tool for accurately detecting skin cancers.